Tarsus Pharmaceuticals, Inc. (TARS) SEC filings
TARS SEC filings moved a median of -0.14% by the close. TARS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TARS overview →
62 measured TARS SEC filing events.
Where these TARS SEC filings landedvs 62 measured TARS SEC filing reactions
| Middle 50% of TARS SEC filing reactions | -2.57% to +2.39% |
|---|---|
| Median reaction (to close) | -0.14% |
| Measured reactions | 62 |
Point-in-time · zero look-ahead
Half of the 62 TARS SEC filing events with a measured close landed between -2.57% and +2.39%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tarsus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.34% | -6.67% | |
| Form 8-K Tarsus Pharmaceuticals, For: Nov 03 | SEC filing · Form 8-K | -1.34% | -6.67% | |
| Form 8-K/A Tarsus Pharmaceuticals, For: Sep 04 | SEC filing · Form 8-K | +0.47% | +2.44% | |
| Form S-3ASR Tarsus Pharmaceuticals, | SEC filing · Form S-3ASR | +0.47% | +2.44% | |
| Form 8-K Tarsus Pharmaceuticals, For: Sep 04 | SEC filing · Form 8-K | +0.89% | -3.60% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +4.09% | +13.36% | |
| Form 8-K Tarsus Pharmaceuticals, For: Aug 05 | SEC filing · Form 8-K | +4.09% | +13.36% | |
| Form 8-K Tarsus Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | +4.09% | +13.36% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jul 31 | SEC filing · Form 8-K | +4.09% | +13.36% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jul 13 | SEC filing · Form 8-K | +2.15% | -2.67% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jul 06 | SEC filing · Form 8-K | +1.01% | -4.33% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jun 25 | SEC filing · Form 8-K | -0.70% | +1.60% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.15% | +2.01% | |
| Form 8-K Tarsus Pharmaceuticals, For: May 06 | SEC filing · Form 8-K | -2.15% | +2.01% | |
| Form ARS Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | -0.85% | -1.21% | |
| Form DEF 14A Tarsus Pharmaceuticals, For: Jun 25 | SEC filing · Form DEF | -0.85% | -1.21% | |
| Form DEFA14A Tarsus Pharmaceuticals, | SEC filing · Form DEFA14A | -0.85% | -1.21% | |
| Form 10-K Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +3.90% | +0.62% | |
| Form 8-K Tarsus Pharmaceuticals, For: Feb 23 | SEC filing · Form 8-K | +3.90% | +0.62% | |
| Form S-8 Tarsus Pharmaceuticals, | SEC filing · Form S-8 | +3.90% | +0.62% | |
| Form 8-K Tarsus Pharmaceuticals, For: Feb 18 | SEC filing · Form 8-K | +1.39% | +1.07% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jan 12 | SEC filing · Form 8-K | -0.57% | -1.90% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.93% | -0.44% | |
| Form 8-K Tarsus Pharmaceuticals, For: Nov 04 | SEC filing · Form 8-K | +0.93% | -0.44% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +2.40% | +6.63% | |
| Form 8-K Tarsus Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | +2.40% | +6.63% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jun 12 | SEC filing · Form 8-K | -3.02% | -1.02% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -4.97% | -4.55% | |
| Form 8-K Tarsus Pharmaceuticals, For: May 01 | SEC filing · Form 8-K | -4.97% | -4.55% | |
| Form ARS Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | -0.44% | +1.76% | |
| Form DEF 14A Tarsus Pharmaceuticals, For: Jun 12 | SEC filing · Form DEF | -0.44% | +1.76% | |
| Form DEFA14A Tarsus Pharmaceuticals, | SEC filing · Form DEFA14A | -0.44% | +1.76% | |
| Form 8-K Tarsus Pharmaceuticals, For: Mar 14 | SEC filing · Form 8-K | +1.79% | +8.21% | |
| Form 8-K Tarsus Pharmaceuticals, For: Mar 12 | SEC filing · Form 8-K | -0.29% | +2.67% | |
| Form 10-K Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.85% | +0.50% | |
| Form 8-K Tarsus Pharmaceuticals, For: Feb 25 | SEC filing · Form 8-K | -9.47% | -12.67% | |
| Form S-8 Tarsus Pharmaceuticals, | SEC filing · Form S-8 | +0.85% | +0.50% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jan 15 | SEC filing · Form 8-K | +0.00% | -0.47% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jan 13 | SEC filing · Form 8-K | +0.30% | -5.90% | |
| Form 8-K Tarsus Pharmaceuticals, For: Dec 16 | SEC filing · Form 8-K | +2.73% | +4.73% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.72% | -8.53% | |
| Form 8-K Tarsus Pharmaceuticals, For: Nov 13 | SEC filing · Form 8-K | -1.72% | -8.53% | |
| Form 8-K Tarsus Pharmaceuticals, For: Nov 01 | SEC filing · Form 8-K | +2.90% | +2.50% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -4.18% | -0.56% | |
| Form 8-K Tarsus Pharmaceuticals, For: Aug 08 | SEC filing · Form 8-K | -4.18% | -0.56% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jun 13 | SEC filing · Form 8-K | +0.48% | -3.01% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -4.79% | -19.91% | |
| Form 8-K Tarsus Pharmaceuticals, For: May 08 | SEC filing · Form 8-K | -4.79% | -19.91% | |
| Form ARS Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +1.15% | -0.59% | |
| Form DEF 14A Tarsus Pharmaceuticals, For: Jun 13 | SEC filing · Form DEF | +1.15% | -0.59% | |
| Form DEFA14A Tarsus Pharmaceuticals, | SEC filing · Form DEFA14A | +1.15% | -0.59% | |
| Form 8-K Tarsus Pharmaceuticals, For: Apr 19 | SEC filing · Form 8-K | +0.56% | +4.88% | |
| Form 8-K Tarsus Pharmaceuticals, For: Mar 05 | SEC filing · Form 8-K | +0.85% | +0.17% | |
| Form 8-K Tarsus Pharmaceuticals, For: Feb 29 | SEC filing · Form 8-K | -2.17% | -2.25% | |
| Form S-3ASR Tarsus Pharmaceuticals, | SEC filing · Form S-3ASR | -0.35% | +7.13% | |
| Form 10-K Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.94% | -6.26% | |
| Form 8-K Tarsus Pharmaceuticals, For: Feb 27 | SEC filing · Form 8-K | -3.12% | +8.40% | |
| Form S-8 Tarsus Pharmaceuticals, | SEC filing · Form S-8 | -1.94% | -6.26% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jan 11 | SEC filing · Form 8-K | -0.87% | +2.27% | |
| Form 8-K Tarsus Pharmaceuticals, For: Jan 08 | SEC filing · Form 8-K | +0.00% | +4.23% | |
| Form 8-K Tarsus Pharmaceuticals, For: Dec 11 | SEC filing · Form 8-K | -1.78% | +2.24% | |
| Form EFFECT Tarsus Pharmaceuticals, | SEC filing · Form EFFECT | -1.45% | -2.06% |
Keep exploring
More TARS: earnings → · analyst actions → · TARS overview →